Jivi Prices, Coupons, Copay Cards & Patient Assistance
Jivi (antihemophilic factor) is a member of the miscellaneous coagulation modifiers drug class and is commonly used for Hemophilia A.
The cost for Jivi (aucl recombinant PEGylated) intravenous powder for injection is around $13 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Jivi prices
Intravenous Powder For Injection
aucl recombinant PEGylated
Jivi intravenous powder for injection
from $13.22
for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $13.22 | $13.22 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Jivi Coupons, Copay Cards and Rebates
Jivi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Jivi Free Trial Program
Eligible patients may receive up a one-month supply (maximum of 40,000 IU); available to new patients 12 and up; form to be filled out by both patient & doctor.
- Applies to:
- Jivi
- Number of uses:
- One-time offer
Form more information phone: 800-288-8374 or Visit website
Jivi Loyalty Program
Eligible commercially insured patients may receive medication at no cost if they are experiencing gaps or changes in their insurance coverage; the patients physician must fill out a form for enrollment.
- Applies to:
- Jivi
- Number of uses:
- Temporary Assistance
Form more information phone: 800-288-8374 or Visit website
Jivi $0 Co-Pay Program
Eligible commercially insured patients pay as little as $0 per prescription with a maximum savings of $20,000 per calendar year.
- Applies to:
- Jivi
- Number of uses:
- Per prescription per calendar year
Form more information phone: 647-245-5619 or Visit website
Jivi $0 Co-Pay Program Rebate
Eligible commercially insured patients may receive a rebate if the pharmacy did not accept the offer; the patient must pay in full for their prescription in order to submit the rebate.
- Applies to:
- Jivi
- Number of uses:
- One rebate per prescription fill
Form more information phone: 647-245-5619 or Visit website
Patient Assistance & Copay Programs for Jivi
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Jivi (antihemophilic factor recombinant PEGylated) Injection; IV Lyophilized powder
More information please phone: 866-316-7263 Visit Website
Provider: Bayer US Patient Assistance Foundation Free Drug Program
Eligibility requirements:- Must be uninsured
- At or below 300% of FPL
- Medically appropriate condition/diagnosis
- Must be residing in the US or Puerto Rico
- Eligibility determined on a case-by-case basis.
- Jivi (antihemophilic factor recombinant PEGylated) Injection; IV Lyophilized powder
More information please phone: 866-228-7723 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Lysteda
Lysteda (tranexamic acid) is used to treat heavy menstrual bleeding. Includes Lysteda side effects ...
Hemlibra
Hemlibra is a monoclonal antibody that functions in place of a natural blood-clotting factor that ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
DDAVP
DDAVP is used for diabetes insipidus, hemophilia a, primary nocturnal enuresis, von Willebrand Disease
Qfitlia
Qfitlia is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia b with ...
Altuviiio
Altuviiio is a once-weekly recombinant fact VIII replacement therapy used by hemophilia A patients ...
Cyklokapron
Cyklokapron is used for bleeding disorder, factor ix deficiency, hemophilia a
Hympavzi
Hympavzi (marstacimab-hncq) may be used to prevent or reduce the frequency of bleeding episodes ...
Fitusiran
Fitusiran systemic is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia ...
Desmopressin
Desmopressin systemic is used for diabetes insipidus, hemophilia a, nocturia, primary nocturnal ...
More about Jivi (antihemophilic factor)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
- En español
Patient resources
Other brands
Altuviiio, Advate, Kovaltry, Afstyla, ... +14 more
Professional resources
Other brands
Altuviiio, Advate, Kovaltry, Afstyla, ... +12 more
